跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brintellix - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brintellix
Approved
STANDARD
Brintellix
H. Lundbeck A/S
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4b52ff92f758efad
Company
H. Lundbeck A/S
Type
Standard
Approval Details
Approval Id
4b52ff92f758efad
Drug Approval Philippines Name
Brintellix
Product Name
Brintellix
Registration Number
DRP-11123
Brand Name
Brintellix
Generic Name
Vortioxetine (as hydrobromide)
Dosage Form
Film-Coated Tablet
Dosage Strength
15 mg
Manufacturer
H. Lundbeck A/S
Importer
Metro Drug, Inc.
Distributor
Metro Drug, Inc.
Company Detail Path
/organization/h-lundbeck-a-s
Issuance Date
25 May 2025
Expiry Date
29 June 2031
Pharmacologic Category
Antidepressant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4b52ff92f758efad
Type
Standard
Back to Philippines FDA Approvals